Skip to main content
RZLT
NASDAQ Life Sciences

Rezolute Launches Underwritten Stock and Pre-Funded Warrant Offering Days After $400M Shelf

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$4.09
Mkt Cap
$374.341M
52W Low
$1.07
52W High
$11.165
52W Position info
282% above low
Off High info
63% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

RZLT has more than doubled off its 52-week low of $1.07.

Summary

Rezolute is raising money through a Morgan Stanley-led underwritten offering of common stock and pre-funded warrants, launched under the $400M universal shelf it put in place on November 5. The timing is telling: cash stood at $90.0M at the end of Q1 fiscal 2027, down from $107.8M, and the company is burning roughly $18.5M a quarter while it waits on upLIFT topline data due mid-December 2026. This comes just over a week after the sunRIZE trial in congenital hyperinsulinism missed its primary endpoint, so the raise lands with the stock already under pressure and the lead program's outlook clouded. Terms — size, price and discount — are not yet disclosed; the pricing of this deal is the number that matters for existing holders. upLIFT topline in mid-December is the next hard catalyst for the story.

At the time of this announcement, RZLT was trading at $4.09 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $374.3M. The 52-week trading range was $1.07 to $11.17. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

RZLT - Latest Insights

RZLT
Nov 13, 2026, 12:27 PM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $3.81
Real-time Price: $3.66 info
Change: -$0.150 (-4%) info
Market Cap: $353.544M info
RZLT
Nov 13, 2026, 6:26 AM EST
Filing Type: FWP
Importance Score:
8
Price at Filing: $4.19
Real-time Price: $3.66 info
Change: -$0.535 (-13%) info
Market Cap: $353.544M info
RZLT
Nov 13, 2026, 6:18 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.91
Real-time Price: $3.66 info
Change: -$0.255 (-7%) info
Market Cap: $353.544M info
RZLT
Nov 13, 2026, 6:15 AM EST
Filing Type: 424B5
Importance Score:
7
Price at Filing: $3.87
Real-time Price: $3.66 info
Change: -$0.215 (-6%) info
Market Cap: $353.544M info
RZLT
Nov 05, 2026, 4:14 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.64
Real-time Price: $3.66 info
Change: +$0.015 (+0.41%) info
Market Cap: $353.544M info